Country:
China (Mainland)
Business Type:Manufacturers
Tel: 187-5252-6868
QQ: 1035253726
Mobile: 18752526868
Tel: 187-5252-6868
Fax:
Province/state: Jiangsu
City: Yangzhou
Street: No.168, Zhicheng Road, Industrial District, Maji Town, Yizheng City, Jiangsu, China
Contact SuppliersBusiness Type:Manufacturers
Year Established:2015
Company Scale:51 - 100
Business Scope:Pazopanib INT Regorafenib INT Sorafenib INT Nilotinib INT Gefitinib INT All Intermediates
Main Markets:North America South America Eastern Europe Southeast Asia Africa Oceania Mid East Eastern Asia Western Europe
Business License:
Tax Registration Certificate:
Organization Code Certificate:
Legal person's id card:
Yangzhou Qinyuan Pharmatech Co.,Ltd is located in the beautiful and rich ancient Yangzhou city, relying on the advantages of Yangzhou Chemical Industrial Park and Yangzhou universities. We are a CDMO enterprise with high efficiency, high quality and best service. The main business involves the research and development of targeted tumor APIs, the production and sales of pharmaceutical intermediates, and the export of chemical products etc. We take the global pharmaceutical market demands as the guidance, integrate the research and development, production and sales of pharmaceutical products with high-level R & D engineers, and a complete set of organic synthesis laboratory. In the research and development, QINYUAN pays attention to scientific and technological innovation, adheres to the creation of imitation combined manufacturing "High & Fine & Top" products, and strives to provide customers with the best quality pharmaceutical products. At present, QINYUAN has established a multi-functional production workshop in Shandong which can realize the automatic production of the whole process from pilot test to industrialization. We always uphold the "PRESENT GOOD PRODUCTS, DEVELOPMENT THROUGH QUALITY" as the Corporate Ideas and Through the continuous upgrading of the industry, improve products’ orientation to meet the diversified demands of the market.